Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Lingbo_Zhang
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Lingbo_Zhang
-
Lingbo Zhang proslijedio/la je Tweet
We’ve just put an additional, cautionary note about the use of preprints on every
@biorxivpreprintpic.twitter.com/08eSXL4dDi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks Medical News Today (MNT)
@mnt for highlighting our recent work from Zhang Lab@CSHL and Lowe Lab -#Leukemia’s unexpected link to#vitamin B-6 https://www.medicalnewstoday.com/articles/leukemias-unexpected-link-to-vitamin-b6?utm_medium=social&utm_source=twitter&utm_campaign=social-sharebar-referred-desktop … via@healthlineHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lingbo Zhang proslijedio/la je Tweet
This week, we've got some exciting stuff on both vitamin B6 and FLT3 inhibitors in
#AML. Don't miss out! https://bit.ly/2spnFCd pic.twitter.com/vA6jyyTb41
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lingbo Zhang proslijedio/la je Tweet
Using #CRISPR, Dr.@Lingbo_Zhang’s lab found that the gene which produces PDXK, the enzyme that helps cells use vitamin B6, proved most important for the growth of acute myeloid#leukemia.@Cancer_Cellhttps://bit.ly/2Tlk6Z1Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lingbo Zhang proslijedio/la je Tweet
CSHL Fellow
@Lingbo_Zhang & collaborators at@sloan_kettering have determined just how#Leukemia is taking advantage of vitamin B6. In doing so, they've created an opportunity to turn the#cancer's addiction into its weakness.https://www.cshl.edu/vitamin-b6-leukemias-deadly-addiction/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks Genetic Engineering & Biotechnology News (GEN)
@GENbio for featuring our work from Zhang Lab@Lingbo_Zhang@CSHL and Lowe Lab@LoweLabMSKCC@sloan_kettering -#Leukemia’s Favorite Fix,#Vitamin B6, Vulnerable to Pharmacological Blockade https://www.genengnews.com/news/leukemias-favorite-fix-vitamin-b6-vulnerable-to-pharmacological-blockade/ … via@GENbioHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to share our discovery from Zhang Lab
@Lingbo_Zhang@CSHL of#leukemia#vitamin B6 addition@Cancer_Cell. Many thanks to the great collaboration with Lowe Lab@LoweLabMSKCC@sloan_kettering. Many thanks to Scott, Chi-Chao, Bo and all collaborators.https://www.cell.com/cancer-cell/fulltext/S1535-6108(19)30572-0#.XhyqUhh-n0o.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It was hard working time in my lab
@CSHL investigating#leukemia#MDS and#blood_cancer. Nice catching up at linkedin and have a great study of biomedical science at Imperial College London@imperialcollege.https://twitter.com/CSHL/status/1045400489649627136 …
0:58Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A glimpse of what
#Zhang_Lab@Lingbo_Zhang https://www.cshl.edu/research/faculty-staff/lingbo-zhang/ …@CSHL is focusing on. Identifying druggable#self_renewal and#metabolism regulators and translating the knowledge into novel#therapeutics for#blood#diseases and#cancers.https://stm.sciencemag.org/content/11/511/eaaw3781 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Miss the imagery campus of Tsinghua University
@Tsinghua_Uni, the Best Global University for Engineering https://www.usnews.com/education/best-global-universities/engineering …https://twitter.com/Tsinghua_Uni/status/1214433987608756224 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Transfusion is a therapeutic option for#MDS cancer and a study shows#iron_chelation may improve overall survival of patients undergoing transfusion. Our recent study@CSHL provides an alternative to target blood cell formation. https://finance.yahoo.com/news/newly-discovered-target-overcomes-drug-180000315.html …https://www.hematologyadvisor.com/home/topics/myelodysplastic-syndromes/survival-outcomes-with-iron-chelation-therapy-for-myelodysplastic-syndrome/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Zhang Lab at
@CSHL studies#blood_cell and develops novel therapeutics for#blood_cancers. From molecular biology and genetics discovery to preclinical development of therapeutic strategies, we work on the boundary between#basic_biology and#translational_medicine.pic.twitter.com/oLciOcBZPQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
My lab has identified a key regulator of blood cell self-renewal and a druggable target for blood cancer MDS and anemia. We are developing pharmacological approaches to treat these diseases that are resistant to current therapy.https://twitter.com/ScienceTM/status/1178383981546479617 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations Omar for this beautiful work!https://twitter.com/AbdelWahablab/status/1199043149722767367 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks to Drug Target Review
@DrugTargetRev for highlighting our recent discovery on#MDS and#anemia from my lab@Lingbo_Zhang at Cold Spring Harbor Laboratory@CSHL. Thanks to Abdel-Wahab Lab@AbdelWahablab for collaborating on this project.https://www.drugtargetreview.com/article/52335/a-novel-target-revealed-for-myelodysplastic-syndrome/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.